§ Funding Round
Series C funding round for Memo Therapeutics raising $22M in May 2024
Series C funding round for Memo Therapeutics raising $22M in May 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Pureos Bioventures | — | — |
Redalpine | — | — |
| Organization | — | |
Swisscanto Invest | — | — |
| Organization | — | |
Vesalius Biocapital | — | — |
| Angel | thomas harth |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$97.9M
Top Valuation
-
Memo Therapeutics raised $22M in a Series C round.
The round was announced on 05/01/24.
